Business Context and Reporting Period
Company: Humana Inc.
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2005
Business Overview: Humana is a major publicly traded health benefits company offering coordinated health insurance coverage through traditional and Internet-based plans. The company operates two primary segments: Government (Medicare Advantage, TRICARE, Medicaid) and Commercial (Fully Insured, Administrative Services Only, Specialty). As of year-end 2005, Humana served approximately 7.1 million medical members and 1.9 million specialty members.
Key Financial Metrics
| Metric | 2005 Value | 2004 Value |
|---|---|---|
| Total Revenues | $14.42 billion | $13.10 billion |
| Net Income | $308.5 million | $280.0 million |
| Diluted EPS | $1.87 | $1.72 |
| Medical Expense Ratio (MER) | 83.2% | 84.1% |
| SG&A Expense Ratio | 15.3% | 14.5% |
| Total Assets | $6.87 billion | $5.66 billion |
| Total Debt | $815.0 million | $636.7 million |
| Cash & Cash Equivalents | $732.0 million | $580.1 million |
| Operating Cash Flow | $625.6 million | $347.8 million |
Material Changes vs. Prior Period
- Revenue Growth: Total revenues increased 10.3% to $14.42 billion, driven primarily by a 31.8% increase in Government segment premiums (led by Medicare Advantage growth) which offset a 7.3% decline in Commercial segment premiums.
- Membership Shifts: Government medical membership grew 4.8% to 3.9 million, while Commercial medical membership declined 4.1% to 3.2 million. Medicare Advantage membership surged 47.9% to 557,800.
- Profitability: Net income rose 10.2% to $308.5 million. The Government segment pretax income increased 18.0%, while the Commercial segment pretax income decreased 30.7% due to competitive pricing pressures and the loss of an unprofitable 89,000-member account.
- Unusual Items: Results included a $71.9 million pretax charge for a class action litigation settlement and $27.0 million in expenses related to Hurricane Katrina. These were partially offset by a $22.8 million tax gain contingency.
- Acquisitions: The company acquired CarePlus Health Plans of Florida (adding 50,400 Medicare members) and Corphealth, Inc. (behavioral health management).
Guidance, Outlook, and Risks
- 2006 Outlook: Management expects Medicare premium revenues to more than double in 2006 due to the rollout of Medicare Part D (Prescription Drug Plans) and expanded Medicare Advantage offerings. Projected Medicare Advantage enrollment is 900,000 to 1.1 million, with PDP enrollment of 1.9 to 2.2 million.
- Margin Expectations: The consolidated SG&A expense ratio is expected to improve to a range of 12% to 13% in 2006 as revenue growth leverages fixed costs. The effective tax rate is projected to be 35% to 37% in 2006.
- Capital Requirements: Anticipated premium growth will require capital contributions to subsidiaries in the range of $450 million to $650 million in 2006.
- Key Risks:
- Government Contract Dependency: 51% of premiums are derived from federal contracts. Changes in CMS payment methodologies (risk adjustment) or loss of TRICARE/Medicaid contracts could materially impact results.
- Medical Cost Inflation: Rising costs for drugs, technology, and services could outpace premium rates.
- Regulatory Environment: Significant exposure to federal and state regulations regarding fraud, abuse, and benefit mandates.
- Competition: Intense pricing competition in the commercial market, particularly in small to mid-market groups.
Investor Verification Checklist
- Medicare Expansion Execution: Verify the actual enrollment numbers for Medicare Part D and Advantage plans in 2006 against the aggressive guidance (900k-1.1M Advantage; 1.9M-2.2M PDP).
- Medical Expense Ratio (MER) Stability: Monitor if the MER remains near 83% given the influx of new, potentially higher-risk Medicare members and general medical inflation.
- Commercial Segment Turnaround: Assess whether the Commercial segment can stabilize membership and improve margins following the 30.7% drop in pretax income and the loss of large group accounts.
- Capital Adequacy: Confirm the company's ability to fund the projected $450M-$650M capital requirement for subsidiaries without diluting shareholders or increasing debt significantly.
- Legal and Regulatory Exposure: Track the final court approval of the $40M physician class action settlement and any new regulatory fines or audits related to government programs.